Stock Movers: CME Group, Oracle, Sandisk (Podcast)

CME Group shares slid in premarket trading after a CyrusOne data‑center cooling failure halted futures and options trading and disrupted equities, FX, bonds and commodities; engineers have restarted chillers and deployed temporary cooling but no timetable for normal operations was provided. Oracle stock fell after Morgan Stanley flagged a three‑year high in a credit‑risk gauge for the company and warned of rising funding and obsolescence risks tied to a large AI spending program; five‑year CDS widened to about 1.25 percentage points per year. SanDisk rallied on reports the US and Japan are weighing a public‑private NAND flash plant in the US with Kioxia and SanDisk as primary investors, though sources cited disputes over capital structure, management control and potential Chinese regulatory hurdles.

Analysis

Market structure: The CME outage exposes concentrated operational risk in exchange plumbing and benefits rivals and backup providers—ICE (ICE) and cloud/DR vendors (CyrusOne competitors, Equinix) are logical short-term beneficiaries as participants seek bilateral hedging and alternative execution venues. Memory onshoring (SNDK/Kioxia) would shift global NAND supply curves left for Asia and raise US domestic capex intensity; expect multi-quarter project timelines and elevated memory pricing if capital commitments >$3–5bn proceed.

Risk assessment: Tail risks include a multi-hour systemic market halt that triggers regulatory fines and mandated redundancy investments (~hundreds of millions) and a 2026 credit shock for ORCL if CDS >200bps leads to rating downgrade, increasing cost of capital and forcing asset sales. Immediate effects (days): volatility spikes, options flow dislocation; short-term (weeks–months): market-share shifts, negotiating windows for the NAND JV; long-term (quarters–years): structural memory supply rebalancing and higher exchange OpEx for redundancy.

Trade implications: Tactical pair trades: favor long ICE vs short CME for 3–6 months to capture flow migration and reputational impact; size 1–2% each with stop if relative spread narrows >50%. Credit/hedge ORCL by buying 6–12 month put spreads 20–30% OTM or 5y CDS protection if CDS breaches 200bps; allocate 0.5–1% portfolio. Take a 1–3% long in SNDK (or 6–12m call spread) targeting +20–40% on formal US-Japan commitment within 60–180 days.

Contrarian angles: The market may overstate permanent share loss for CME—switching costs and liquidity fragmentation favor incumbents, so a >25% price drop would be a durable buying opportunity. ORCL’s balance-sheet fear could be partly priced-in; watch net-debt/EBITDA and 2026 capex guidance—if management outlines clear financing (asset sales/term debt) the credit selloff will reverse. SNDK upside is binary; price accordingly and use event-driven sizing.

Key Decisions for Investors

• Establish a 1–3% long position in SNDK or a 6–12 month call spread sized to 1–2% portfolio risk; target +20–40% if a US-Japan NAND JV is announced within 60–180 days, cut to -20% if negotiations collapse or Chinese restrictions materialize.
• Implement a pair trade: long ICE (1–2% position) and short CME (1–1.5%) for 3–6 months to capture potential flow migration; close if ICE/CME relative spread tightens by >50% or CME operational remediation/compensation announced.
• Buy downside protection on ORCL: either purchase 5-year CDS protection if market quotes >200bps or enter a 6–12 month put spread ~20–30% OTM sized 0.5–1% portfolio as insurance; increase hedge if ORCL guidance for 2026 capex implies >$3bn incremental funding need.
• Reduce net exposure to pure exchange/market-structure names by ~25% within quant/market-making buckets and redeploy +2–4% into US semiconductor supply chain and memory-capex beneficiaries (SNDK, semiconductor equipment suppliers), using event-driven scaling on official announcements.